Interviews
View More
Competition is Key to Healthcare System Stability for Employers, Providers and Patients, Expert Says

While the impact of Medicaid changes on employer-sponsored insurance remains to be seen, competition between providers is a steadfast way to stabilize the system for everyone, according to Christoph Dankert, chief network officer of Carrum Health.

Study Insights: Exploring Healthcare Utilization in T1D

Panelists discuss how their study compared healthcare resource utilization between newly diagnosed patients with type 1 diabetes with and without prior type 2 diabetes misdiagnosis, using a retrospective claims database analysis to examine utilization patterns across different healthcare services.

HIV Mobile Care Clinics Can Overcome Healthcare Barriers

Sonali Kulkarni, M.D., M.P.H., Medical Director in the Division of HIV and STD Programs at the Los Angeles County Department of Public Health, recently sat down with Managed Healthcare Executive to explain the barriers within the traditional healthcare system for homeless HIV patients and the importance of mobile care clinics.

The Shifting Landscape of Healthcare Payments

The financial balancing act between providers, government programs and commercial insurers, according to Christoph Dankert, chief network officer of Carrum Health.

Importance of Early Diagnosis of Vitiligo

An expert discusses how early diagnosis of vitiligo is primarily important for limiting the area requiring repigmentation, while explaining that genetic predisposition, autoimmune thyroid disease and skin trauma are key risk factors for developing the condition.

Vitiligo Presentation in Different Patient Populations

An expert discusses how vitiligo involves a complex autoimmune mechanism where the body’s immune system destroys melanocytes, presenting as either segmental vitiligo (rapid, localized to one body area) or nonsegmental vitiligo (slower, scattered patches), with treatment success depending on the presence of pigmented hairs in affected areas.

Historical Standards of Care in Metastatic SCAC

A panelist discusses how the historical standard of care for metastatic squamous cell anal carcinoma evolved from cisplatin-based regimens to carboplatin and paclitaxel as the established backbone treatment based on the InterAACT trial, which demonstrated superior progression-free survival and overall survival (20 months vs 12 months) with better tolerability, until recent changes with the POD1UM-303 trial shifted the current standard of care.

Defining High-Risk Populations in Squamous Cell Anal Carcinoma

A panelist discusses how squamous cell cancer of the anal canal has nearly doubled in incidence over 30 years, with human papillomavirus infection being the primary risk factor that is significantly amplified by immunosuppression from conditions like HIV, immunosuppressive medications or organ transplantation, particularly affecting older patients and women at higher rates.

Diagnosing Type 1 Diabetes: Clinical Challenges and Consequences

Panelists discuss how type 1 diabetes is diagnosed using autoantibody testing and the challenges clinicians face, including the common misdiagnosis of adults with type 1 diabetes as having type 2 diabetes due to age bias and the misconception that type 1 diabetes only occurs in childhood.

Official Media Partners